Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/MR with 68Ga-PSMA and 68Ga-RM2 for Prostate Cancer Restaging
NCT05806853Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jun 2020
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Diagnostic accuracy of 68Ga-PSMA PET/MR compared to 68Ga-RM2 PET/MR. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT05806853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05806853.